BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23485561)

  • 1. Progesterone receptor isoforms PRA and PRB differentially contribute to breast cancer cell migration through interaction with focal adhesion kinase complexes.
    Bellance C; Khan JA; Meduri G; Guiochon-Mantel A; Lombès M; Loosfelt H
    Mol Biol Cell; 2013 May; 24(9):1363-74. PubMed ID: 23485561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p38 and p42/44 MAPKs differentially regulate progesterone receptor A and B isoform stabilization.
    Khan JA; Amazit L; Bellance C; Guiochon-Mantel A; Lombès M; Loosfelt H
    Mol Endocrinol; 2011 Oct; 25(10):1710-24. PubMed ID: 21816898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of breast cancer-associated genes by progesterone receptor isoforms PRA and PRB in a new bi-inducible breast cancer cell line.
    Khan JA; Bellance C; Guiochon-Mantel A; Lombès M; Loosfelt H
    PLoS One; 2012; 7(9):e45993. PubMed ID: 23029355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential quantitative proteomics reveals key proteins related to phenotypic changes of breast cancer cells expressing progesterone receptor A.
    Pateetin P; Pisitkun T; McGowan E; Boonyaratanakornkit V
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105560. PubMed ID: 31809870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered progesterone receptor isoform expression remodels progestin responsiveness of breast cancer cells.
    Graham JD; Yager ML; Hill HD; Byth K; O'Neill GM; Clarke CL
    Mol Endocrinol; 2005 Nov; 19(11):2713-35. PubMed ID: 15976005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone receptor isoform ratio dictates antiprogestin/progestin effects on breast cancer growth and metastases: A role for NDRG1.
    Abascal MF; Elia A; Alvarez M; Pataccini G; Sequeira G; Riggio M; Figueroa V; Lamb CA; Rojas PA; Spengler E; Martínez-Vazquez P; Burruchaga J; Liguori M; Sahores A; Wargon V; Molinolo A; Hewitt S; Lombes M; Sartorius C; Vanzulli SI; Giulianelli S; Lanari C
    Int J Cancer; 2022 May; 150(9):1481-1496. PubMed ID: 34935137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone receptor (PR) isoforms PRA and PRB differentially regulate expression of the breast cancer resistance protein in human placental choriocarcinoma BeWo cells.
    Wang H; Lee EW; Zhou L; Leung PC; Ross DD; Unadkat JD; Mao Q
    Mol Pharmacol; 2008 Mar; 73(3):845-54. PubMed ID: 18042733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new class of orthosteric uPAR·uPA small-molecule antagonists are allosteric inhibitors of the uPAR·vitronectin interaction.
    Liu D; Zhou D; Wang B; Knabe WE; Meroueh SO
    ACS Chem Biol; 2015 Jun; 10(6):1521-34. PubMed ID: 25671694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aeroallergen Der p 2 promotes motility of human non-small cell lung cancer cells via toll-like receptor-mediated up-regulation of urokinase-type plasminogen activator and integrin/focal adhesion kinase signaling.
    Lin CH; Lin HH; Kuo CY; Kao SH
    Oncotarget; 2017 Feb; 8(7):11316-11328. PubMed ID: 28076322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B.
    Wu J; Richer J; Horwitz KB; Hyder SM
    Cancer Res; 2004 Mar; 64(6):2238-44. PubMed ID: 15026368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of overexpression of progesterone receptor A on endogenous progestin-sensitive endpoints in breast cancer cells.
    McGowan EM; Clarke CL
    Mol Endocrinol; 1999 Oct; 13(10):1657-71. PubMed ID: 10517668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.
    Rojas PA; May M; Sequeira GR; Elia A; Alvarez M; Martínez P; Gonzalez P; Hewitt S; He X; Perou CM; Molinolo A; Gibbons L; Abba MC; Gass H; Lanari C
    J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of uPAR retards radiation-induced invasion and migration mediated by integrin β1/FAK signaling in medulloblastoma.
    Nalla AK; Asuthkar S; Bhoopathi P; Gujrati M; Dinh DH; Rao JS
    PLoS One; 2010 Sep; 5(9):e13006. PubMed ID: 20886051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple SILAC identified progestin-independent and dependent PRA and PRB interacting partners in breast cancer.
    Pateetin P; Hutvagner G; Bajan S; Padula MP; McGowan EM; Boonyaratanakornkit V
    Sci Data; 2021 Apr; 8(1):100. PubMed ID: 33846359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium.
    Arnett-Mansfield RL; DeFazio A; Mote PA; Clarke CL
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1429-42. PubMed ID: 15001645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ulipristal Acetate Inhibits Progesterone Receptor Isoform A-Mediated Human Breast Cancer Proliferation and BCl2-L1 Expression.
    Esber N; Le Billan F; Resche-Rigon M; Loosfelt H; Lombès M; Chabbert-Buffet N
    PLoS One; 2015; 10(10):e0140795. PubMed ID: 26474308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters.
    Wargon V; Riggio M; Giulianelli S; Sequeira GR; Rojas P; May M; Polo ML; Gorostiaga MA; Jacobsen B; Molinolo A; Novaro V; Lanari C
    Int J Cancer; 2015 Jun; 136(11):2680-92. PubMed ID: 25363551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis.
    Mote PA; Bartow S; Tran N; Clarke CL
    Breast Cancer Res Treat; 2002 Mar; 72(2):163-72. PubMed ID: 12038707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of urokinase-type plasminogen activator (uPA), its receptor (uPAR), and inhibitor (PAI-1) in human breast carcinomas and their clinical relevance.
    Andres SA; Edwards AB; Wittliff JL
    J Clin Lab Anal; 2012 Feb; 26(2):93-103. PubMed ID: 22467324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.